Filing Details

Accession Number:
0001104659-23-122940
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-12-01 20:31:35
Reporting Period:
2023-11-16
Accepted Time:
2023-12-01 20:31:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1072379 Northwest Biotherapeutics Inc NWBO Pharmaceutical Preparations (2834) 943306718
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1629113 Navid Malik C/O Northwest Biotherapeutics, Inc.
48 Montgomery Lane, Suite 800
Bethesda MD 20814
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-11-16 125,000 $0.84 445,000 No 4 S Direct
Common Stock Acquisiton 2023-11-17 150,000 $0.82 295,000 No 4 S Direct
Common Stock Acquisiton 2023-11-17 295,000 $0.82 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Dr. Malik sold a total of 570,000 shares solely to pay a tax obligation, and all proceeds are being used for such taxes.